The European Board of Anaesthesiology recommendations for safe medication practice First update
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F44555601%3A13450%2F17%3A43894535" target="_blank" >RIV/44555601:13450/17:43894535 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11150/17:10369573 RIV/00179906:_____/17:10369573
Výsledek na webu
<a href="http://www.ssaim.sk/wp-content/uploads/2015/11/safety_medication_EJA_2017.pdf" target="_blank" >http://www.ssaim.sk/wp-content/uploads/2015/11/safety_medication_EJA_2017.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/EJA.0000000000000531" target="_blank" >10.1097/EJA.0000000000000531</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The European Board of Anaesthesiology recommendations for safe medication practice First update
Popis výsledku v původním jazyce
These European Board of Anaesthesiology (EBA) recommendations for safe medication practice replace the first edition of the EBA recommendations published in 2011. They were updated because evidence from critical incident reporting systems continues to show that medication errors remain a major safety issue in anaesthesia, intensive care, emergency medicine and pain medicine, and there is an ongoing need for relevant up-to-date clinical guidance for practising anaesthesiologists. The recommendations are based on evidence wherever possible, with a focus on patient safety, and are primarily aimed at anaesthesiologists practising in Europe, although many will be applicable elsewhere. They emphasise the importance of correct labelling practice and the value of incident reporting so that lessons can be learned, risks reduced and a safety culture developed.
Název v anglickém jazyce
The European Board of Anaesthesiology recommendations for safe medication practice First update
Popis výsledku anglicky
These European Board of Anaesthesiology (EBA) recommendations for safe medication practice replace the first edition of the EBA recommendations published in 2011. They were updated because evidence from critical incident reporting systems continues to show that medication errors remain a major safety issue in anaesthesia, intensive care, emergency medicine and pain medicine, and there is an ongoing need for relevant up-to-date clinical guidance for practising anaesthesiologists. The recommendations are based on evidence wherever possible, with a focus on patient safety, and are primarily aimed at anaesthesiologists practising in Europe, although many will be applicable elsewhere. They emphasise the importance of correct labelling practice and the value of incident reporting so that lessons can be learned, risks reduced and a safety culture developed.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30223 - Anaesthesiology
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2017
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
European Journal of Anaesthesiology
ISSN
0265-0215
e-ISSN
—
Svazek periodika
34
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
4
Strana od-do
4-7
Kód UT WoS článku
000390218600002
EID výsledku v databázi Scopus
2-s2.0-85015398393